Pricing Turning Point: The Case for Innovating Pharma’s Model

Juan Rivera and Caitlyn MacDonald have outlined potential strategy shifts that could help evolve the industry’s pricing playbook—with a look at implementation lessons from other sectors and the unique hurdles to large-scale adoption in pharma. 

This article was originally published in Pharmexec.com.

In this article, our experts talk about: 

• Challenges under the current price model
• The model's integral role in Pharma's future strategy
• Paving the way for new price models
• Education and Alignment

Please click here to read the full article.